Composition
- Active ingredients
- SUMATRIPTAN SUCCINATE EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SUMATRIPTAN SUCCINATE EQ 25MG BASE · TabletNDA020132-002 · Prescription
- SUMATRIPTAN SUCCINATE EQ 50MG BASE · TabletNDA020132-003 · Prescription
- SUMATRIPTAN SUCCINATE EQ 100MG BASE · TabletNDA020132-001 · Prescription
- SUMATRIPTAN SUCCINATE EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020080.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Imitrex
- Active substance
- sumatriptan succinate
- Route
- Subcutaneous
- Dosage form
- Injectable
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 28 Dec 1992
- Application
- NDA020080-001